Across TCGA pan-cancer cohorts, WDR3 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated WDR3 data layer compared with 23 for mass-spec protein and 8 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher WDR3 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated WDR3 expression acts as an unfavorable survival marker, although some lineages such as LSCC and GBM show a favorable association.
LSCC, PDAC, and HNSC are the cancer types where WDR3 mass-spec protein most reproducibly stratifies survival.